202 related articles for article (PubMed ID: 27033700)
1. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
Zou H; Wu Y; Brew K
J Biol Chem; 2016 May; 291(21):11348-58. PubMed ID: 27033700
[TBL] [Abstract][Full Text] [Related]
2. Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.
Wu Y; Wei S; Van Doren SR; Brew K
J Biol Chem; 2011 May; 286(19):16891-9. PubMed ID: 21454617
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
Batra J; Robinson J; Soares AS; Fields AP; Radisky DC; Radisky ES
J Biol Chem; 2012 May; 287(19):15935-46. PubMed ID: 22427646
[TBL] [Abstract][Full Text] [Related]
4. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
[TBL] [Abstract][Full Text] [Related]
5. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
8. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; KnaĆ¼per V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
[TBL] [Abstract][Full Text] [Related]
10. Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3.
Arumugam S; Gao G; Patton BL; Semenchenko V; Brew K; Van Doren SR
J Mol Biol; 2003 Mar; 327(3):719-34. PubMed ID: 12634064
[TBL] [Abstract][Full Text] [Related]
11. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
Wei S; Chen Y; Chung L; Nagase H; Brew K
J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
[TBL] [Abstract][Full Text] [Related]
12. Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10.
Raeeszadeh-Sarmazdeh M; Coban M; Mahajan S; Hockla A; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2022 Mar; 298(3):101654. PubMed ID: 35101440
[TBL] [Abstract][Full Text] [Related]
13. Quantitative mapping of binding specificity landscapes for homologous targets by using a high-throughput method.
Aharon L; Aharoni SL; Radisky ES; Papo N
Biochem J; 2020 May; 477(9):1701-1719. PubMed ID: 32296833
[TBL] [Abstract][Full Text] [Related]
14. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
[TBL] [Abstract][Full Text] [Related]
15. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
[TBL] [Abstract][Full Text] [Related]
16. Direct expression of active human tissue inhibitors of metalloproteinases by periplasmic secretion in Escherichia coli.
Lee KB; Nam DH; Nuhn JAM; Wang J; Schneider IC; Ge X
Microb Cell Fact; 2017 Apr; 16(1):73. PubMed ID: 28454584
[TBL] [Abstract][Full Text] [Related]
17. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
Huang Y; Shen L; Cai A; Xiao J
J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
Wang X; Li Y; Chen J; Guo X; Guan H; Li C
Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
[TBL] [Abstract][Full Text] [Related]
19. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.
Kyaw-Tanner MT; Wattle O; van Eps AW; Pollitt CC
Equine Vet J; 2008 Jul; 40(5):482-7. PubMed ID: 18178538
[TBL] [Abstract][Full Text] [Related]
20. The presence of outer arm fucose residues on the N-glycans of tissue inhibitor of metalloproteinases-1 reduces its activity.
Kim HIe; Saldova R; Park JH; Lee YH; Harvey DJ; Wormald MR; Wynne K; Elia G; Kim HJ; Rudd PM; Lee ST
J Proteome Res; 2013 Aug; 12(8):3547-60. PubMed ID: 23815085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]